2026 Cell & Gene Meeting on the Mesa
Join us at the 2026 Meeting on the Mesa to explore what’s next in viral vector.
October 5–7, 2026 | Phoenix, Arizona | Table #F12
About Meeting on the Mesa
The Cell & Gene Meeting on the Mesa is a leading annual conference bringing together senior executives and decision-makers from across the cell and gene therapy industry to help advance innovative research toward potential cures.
Focused on the commercialization challenges facing the sector, the meeting covers topics ranging from clinical trial design and alternative payment models to scale-up, manufacturing, and supply chain strategies for advanced therapies.
The program features expert-led panels, extensive partnering opportunities, exclusive networking, and 100+ presentations from leading companies, providing a forum for building partnerships and exploring the latest progress across the field.
Event details
Date: October 5-7, 2026
Format: In-person
Location: Arizona Biltmore, Phoenix, AZ
Table: #F12
Event website:
https://meetingonthemesa.com/
Why Thermo Fisher Scientific?
The next generation of gene therapies demands more than manufacturing capacity. It requires innovative technologies, robust processes, and a CDMO that can help you navigate the path from development through manufacturing. But choosing the right CDMO is about more than capabilities and integrated services. It’s about finding a team you can trust to grow alongside you as your science, process, and program evolve.
At Thermo Fisher Scientific, we collaborate with biotechnology and pharmaceutical drug developers to help translate scientific innovation into practical development and manufacturing strategies. By bringing together deep expertise across process development, manufacturing, and analytical development, we help you make informed decisions, address complexity, and prepare for what comes next on your journey to market.
What’s next in viral vector manufacturing?
Lentiviral vectors are enabling advances across ex vivo and emerging in vivo gene therapies, but scaling manufacturing can present significant challenges, including infectious yield, particle fragility, and process sensitivity. Our scientists are advancing lentiviral vector (LVV) manufacturing with a new LV cell line and optimized upstream process designed to support robust, scalable production.
Our process development approach combines Design of Experiments (DOE), single-use bioreactors, and high-throughput analytical workflows to systematically evaluate critical manufacturing parameters. Optimized conditions achieved infectious titers in the ~1E7 TU/mL range at harvest, while scaled production reproduced small-scale performance across bioreactor platforms.
What this means for your program:
- Innovation: Explore a new lentiviral vector (LV) cell line and optimized upstream manufacturing approach.
- Scalability: Discover processes designed to translate from development to larger-scale manufacturing.
- Process robustness: Build confidence through systematic process optimization and scale-up evaluation.
- Application-specific strategies: Explore differentiated downstream approaches for ex vivo and in vivo applications.
Meet us at Meeting on the Mesa
Whether you’re optimizing an existing process, planning your next scale-up, or evaluating a path toward clinical or commercial manufacturing, our experts can help you determine the right next steps for your program.
Connect with Thermo Fisher Scientific experts to discuss:
- Viral vector and mRNA manufacturing services
- Our new LV cell line and upstream process optimization
- CMC and manufacturing strategy approaches
- Strategic and scalable CDMO partnerships
Meet Thermo Fisher Scientific’s experts at Cell & Gene Meeting on the Mesa to explore our complete suite of CDMO and CRO services for advanced therapies.
Schedule a private meeting with our team during the event by clicking below.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon